Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Steven M. Devine"'
Autor:
Todd A. Fehniger, Steven M. Devine, Samantha Jaglowski, Nancy L. Bartlett, Lai Wei, Mitch A. Phelps, Beth A. Christian, Xiaohua Zhu, Jennifer Sexton, Joseph Maly, Nina D. Wagner-Johnston, Kristie A. Blum
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:347-353
Background Lenalidomide and panobinostat have shown single-agent efficacy of 14% to 50% and 27% to 58%, respectively, in Hodgkin lymphoma (HL). This phase I/II study was conducted to determine the maximum tolerated dose (MTD), safety, and efficacy of
Autor:
Heather Landau, Siddhartha Ganguly, Ravi Vij, Yvonne A. Efebera, Mary M. Horowitz, Asad Bashey, George Somlo, Cristina Gasparetto, Beth Blackwell, Amrita Krishnan, John Koreth, Philip L. McCarthy, Edward A. Stadtmauer, Marcelo C. Pasquini, Dan T. Vogl, David H. Vesole, Courtney Nelson, Kristin Knust, Nina Shah, Brian McClune, Nancy L. Geller, Steven M. Devine, Hari Parameswaran, Sergio Giralt, Muzaffar H. Qazilbash
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:e5
Autor:
Joseph M. Flynn, Steven M. Devine, Sam Penza, Nyla A. Heerema, Jeffrey A. Jones, Leslie A. Andritsos, John C. Byrd, Kristie A. Blum, Robert A. Baiocchi, Beth A. Christian, Pierluigi Porcu, Jonathon B. Cohen, Amy S. Ruppert
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:278-285.e1
Background Pretreatment cytogenetics are not routinely used to predict patient outcomes in mantle cell lymphoma (MCL). Based on the prognostic utility of cytogenetics in other diseases, we reviewed the effect of a complex karyotype (CK) in MCL. Patie